Days after proposing to settle a data breach lawsuit for $30 million, 18-year-old genetic testing company 23andMe now faces ...

The history of the DNA-testing startup reads like a checklist of Silicon Valley clichés: founder squabbles, gobs of cash, a ...

Me, the personal genomics company, went public in early 2021 via a merger with a blank check company that valued it at $3.5 ...

Following a monthslong battle over CEO Anne Wojcicki’s plans to take 23andMe private, all seven independent members of its ...

Once a hot $6 billion biotech company, 23andMe is now on the verge of collapse. What could happen to the DNA data of its 14 million customers?

While genetic testing is not outright illegal in Israel, there are significant legal restrictions that limit access to DNA ...

On Sept. 23, the board of directors at 23andMe, a prominent DNA testing company, announced their resignation following a series of disagreements with CEO Ann ...

Genetics testing company 23andMe has agreed to pay $30 million and provide three years of security monitoring to settle a ...

( JTA) — The genetic testing company 23andMe has agreed to pay $30 million to American plaintiffs to settle a lawsuit over a ...

SUNNYVALE, Calif., Sept. 25, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co., (Nasdaq: ME), a leading human genetics and preventive health ...

A 73-year-old kidnapping case was solved when the family of Luis Armando Albino, a 6-year-old boy abducted in California on ...

The stock of 23andMe has a consensus Moderate Buy rating based on the views of two Wall Street analysts. One analyst rates the stock a Buy and the other rates it a Hold. There are no Sell ratings ...